Apellis Pharmaceuticals Inc (APLS) earnings · rev $1.00B
These earnings events as JSON? API free 100/dayApellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
This APLS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported APLS revenue for 2025-12-31 was $1.00B. Net income was $22.4M. Revenue was up 28.5% from 2024-12-31 to 2025-12-31. APLS currently screens at market cap $2.29B.
When the next APLS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 28.5% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full APLS research stays on the stock page; the tape stays on the quote page.
APLS earnings FAQ
What are APLS's latest revenue and net income?
Latest cached Apellis Pharmaceuticals Inc (APLS) revenue for Dec 31, 2025 was $1.00B. Net income was $22.4M. Statements: https://lician.com/financials/apls
What is APLS's latest diluted EPS?
Latest cached Apellis Pharmaceuticals Inc (APLS) diluted EPS for Dec 31, 2025 was $0.20.
What period does the latest APLS earnings print cover?
The latest cached Apellis Pharmaceuticals Inc (APLS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did APLS revenue change from the prior cached period?
Cached Apellis Pharmaceuticals Inc (APLS) revenue was up 28.5% from $781.4M (Dec 31, 2024) to $1.00B (Dec 31, 2025). Statements: https://lician.com/financials/apls
Where are APLS earnings listed?
Cached earnings facts for Apellis Pharmaceuticals Inc (APLS) are listed at https://lician.com/earnings/apls. Statements: https://lician.com/financials/apls
Not investment advice.